Our Biotech Journey:
From a Mother’s Journey to a Global Mission
In the world of rare diseases, time is everything—and for many, hope arrives too late. But sometimes, change begins with just one child.
AdiLabs.ai was born from the extraordinary journey of Adi—the first child in Texas, and one of the first in the world, to receive a breakthrough gene therapy for a rare condition.
Behind him is his mother, Naveena Allampalli—an award-winning AI leader who transformed personal pain into a purpose-driven mission.
In June 2023, Adi was diagnosed unexpectedly. No treatment existed. Just two weeks later, a gene therapy—15 years in the making—was approved. A one-time, $3.2M dose, available only to children aged 4–5. Adi made it—just in time.
That moment changed everything.Adi’s story became a wake-up call. And
AdiLabs became the beginning of a global movement to fix what’s broken in rare disease care—through the power of AI, data, and determination.
Adi means “beginning.”His journey sparked AdiLabs.ai—a new beginning for rare disease innovation, built to change the system for millions.
Rare Disease Crisis
The system is broken. And millions of lives are at stake.
10000
Rare diseases
300
Million people effected
50%
Are neurological, nuromuscular, or genetic cancers
90%
Of rare diseases lack an approved treatment
The system is broken. And millions of lives are at stake.
Once diagnosed, patients face fragmented care, limited monitoring, and little guidance for long-term management.
Clinicians lack tools for early diagnosis, monitoring, and outcome tracking
Drug development is slow, risky, and fragmented due to small patient populations and siloed data
The Impact we Aim For
At Adilabs, we believe every rare disease patient deserves a faster diagnosis, access to life-saving treatments, and personalized care after therapy.
Our Approach
One Unified Platform. Built for the Rare Disease Ecosystem.
Our AI-powered platform connects stakeholders across the rare disease lifecycle—bridging gaps between diagnosis, treatment, and ongoing care.
AdiCare
AdiCare
Clinicians & Hospitals
AdiDx
AdiDx
Researchers & Academic La
AdiTrails
AdiTrials
Pharma & Biotechs
Current Initiatives
Starting at the Point of Care: Adicare
Rare Disease Intelligence Platform for Clinicians/Hospitals.
AdiLabs is beginning where impact is most immediate—in the clinic & hospitals
AdiCare
Real-Time Clinical Intelligence Platform for Rare Disease Care
Researching and developing a unified AI platform transforming how rare diseases are monitored, managed, and treated. Starting with rare neuromuscular, neurology.
Capabilities
Real-Time Monitoring 24/7
Predictive Precision Intelligence
Gene Therapy Ready
Biomarker Intelligence
Unified multimodal data view
Modular & Scalable Built for clinicians, hospitals, and biopharma
Personalized Medicine
Advancing personalized medicine by harnessing real-world data, AI-driven insights, and multi-omics intelligence to deliver care that’s tailored to each patient’s unique biology and disease journey.
Capabilities
Multi-Omics Intelligence
AI-Driven Risk Stratification
Precision Clinical Insights
Cohort & Response Analytics:
Our Mission
To build the world’s first end-to-end rare disease intelligence platform—powered by AI, multi-omics, and real-world evidence—to accelerate drug discovery, development, and clinical care for better outcomes.
